We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


SGD Pharma Expands Capacity of Siliconized Glass Vials With the Announcement of a New Siliconization Line

Glass vials.
Credit: SGD Pharma.
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

SGD Pharma, announces the opening of a new siliconization operation at its state-of-the-art Saint-Quentin Lamotte (SQLM) plant. The company enhances its already extensive range of in-house services by internalizing its glass siliconization offer, further ensuring responsiveness, security of supply and improved flexibility of vial sizes.      


Glass vials are regularly used for pharmaceutical packaging, though there is a growing market need for primary packaging that is suited to more sensitive, aggressive and viscous drug products. The application of a micro-layer silicone-based internal coating to the container provides a protective barrier that minimizes interaction between the drug product and the primary packaging, while preserving the integrity of sensitive therapeutic products. 


SGD Pharma’s treatment uses an optimized spraying process that provides uniform coverage of the vial surface, ensuring a higher performance of the internal silicone thin-layer. The process is executed with rigorous quality control under an ISO 8 clean room, in an ISO 15378 certified facility.


This new operation at SQLM is suitable for all glass types in vial sizes ranging from 3ml to 500ml in both clear and amber glass, at a high processing capacity. The treatment is ideal for a wide variety of market applications including: anti-infectives, parenteral nutrition, diagnostics, animal health and oncology to name a few.


More details on the new line at SQLM and the benefits of internal siliconization will be showcased by SGD Pharma on its booth (B60&B62) at Pharmapack 2024.